Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
11/09/1995 | WO1995029697A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
11/09/1995 | WO1995029694A1 Collagen hydrolysis accelerator |
11/09/1995 | WO1995029675A1 Method and composition for treating renal disease and failure |
11/09/1995 | CA2690298A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
11/09/1995 | CA2189070A1 Method and composition for treating renal disease and failure |
11/08/1995 | EP0680758A1 Pharmaceutical compositions containing tamoxifen or analogs and raloxifene or analogs |
11/08/1995 | EP0680472A1 4,5-diphenylimidazole derivatives, their preparation and their use as acyl coenzyme a: cholesterol-0-acyl-transferase (acat) inhibitor |
11/08/1995 | EP0680336A1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants |
11/08/1995 | EP0680327A1 Therapeutic uses and delivery systems of dehydroepiandrosterone |
11/07/1995 | US5464872 Sleep disorders |
11/07/1995 | US5464756 Processes and compositions for the isolation of human relaxin |
11/06/1995 | CA2148302A1 Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
11/02/1995 | WO1995029152A1 Benzamide derivatives as vasopressin antagonists |
11/02/1995 | WO1995029148A1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them |
11/02/1995 | WO1995028932A1 Transdermal delivery of alpha adrenoceptor blocking agents |
11/02/1995 | WO1995028930A1 Dosage forms and method for ameliorating male erectile dysfunction |
11/02/1995 | WO1995028921A1 Ecadotril as a renal protective agent |
11/02/1995 | EP0679091A1 Chemotactic factors for human spermatozoa and their use in human assisted fertilization |
11/02/1995 | EP0679084A1 Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
10/31/1995 | US5462962 Tetrahydrobenz[c,d]indole serotonin agonists |
10/31/1995 | US5462950 Administering raloxifene or salt |
10/29/1995 | CA2147925A1 Pseudopeptides derived from neurokinins; process for preparing the same and pharmaceutical compositions containing them |
10/26/1995 | WO1995028480A1 Methods of use of uncoated gel particles |
10/26/1995 | WO1995028397A1 Alpha1c adrenergic receptor antagonists |
10/26/1995 | WO1995028388A1 Quinolone derivative for treatment of urinary incontinence |
10/26/1995 | WO1995028157A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
10/26/1995 | CA2187773A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
10/26/1995 | CA2187767A1 Alpha1c adrenergic receptor antagonists |
10/26/1995 | CA2187526A1 Methods of use of uncoated gel particles |
10/25/1995 | EP0678503A1 Delta-amino-gamma-hydroxy-omega-aryl alkanoic acid amides with enzyme especially renin inhibiting activities |
10/25/1995 | EP0678101A1 Growth differentiation factor-9 |
10/24/1995 | US5461065 Methods for inhibiting endometriosis |
10/24/1995 | US5461064 Methods of inhibiting atrophy of the skin and vagina |
10/24/1995 | CA1337420C (substituted aralkyl) heterocyclic compounds |
10/19/1995 | WO1995027723A1 Receptor modulating agents and methods relating thereto |
10/19/1995 | WO1995027503A1 Antirestenosis protein |
10/19/1995 | WO1995027500A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES |
10/19/1995 | WO1995027490A1 Use of serotonin antagonists (5ht3) for treating fibromyalgia |
10/19/1995 | WO1995017904A3 Botulinum toxins for treating various disorders and associated pain |
10/19/1995 | CA2187345A1 Treatment of autoimmune disease using oral tolerization and/or th2-enhancing cytokines |
10/18/1995 | EP0677059A1 Endothelin converting enzyme inhibitors |
10/18/1995 | EP0677042A1 Selective ligands of receptors 5-ht 1d?-5ht 1b? derived from indole-piperazine useful as medicaments |
10/18/1995 | EP0676959A1 Endothelin receptor antagonists |
10/18/1995 | CN1110177A Materials and methods for immunocontraception |
10/18/1995 | CN1110171A Shuangshi Zaishengjing oral liquor and preparation method thereof |
10/17/1995 | US5459156 Angiotensin converting enzyme inhibitors, hypotensive, atherosclerosis |
10/17/1995 | US5459142 Pyrazinyl and piperazinyl substituted pyrazine compounds |
10/17/1995 | CA1337351C Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
10/12/1995 | WO1995027055A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY |
10/12/1995 | WO1995026960A1 Physiologically active substance ei-1507 |
10/12/1995 | WO1995026748A1 Use of mcp-1 for inducing ripening of the cervix |
10/12/1995 | WO1995026730A1 Combined hormonal contraception pharmaceutical preparation |
10/12/1995 | WO1995026723A1 Novel substituted tryptamines, phenalkylamines and related compounds |
10/12/1995 | WO1995026716A1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments |
10/12/1995 | CA2187166A1 Novel substituted tryptamines, phenalkylamines and related compounds |
10/12/1995 | CA2186908A1 .alpha.-1-antichymotrypsin analogues having elastase inhibitory activity |
10/12/1995 | CA2186739A1 Combined hormonal contraception pharmaceutical preparation |
10/12/1995 | CA2186370A1 Use of mcp-1 for inducing ripening of the cervix |
10/11/1995 | EP0676395A2 Substituted N-heteroaroylguanidines, as inhibitors of sodium-hydrogen exchange, as antiarrhythmic agents and as inhibitors of the proliferation of cells |
10/11/1995 | EP0676202A2 Use of aromatic steroids substituted in 3-position by a disubstituted aminoalkoxy chain for the manufacture of a medicament for the control of fertility, in particular male fertility |
10/11/1995 | EP0675902A1 Endothelin antagonists |
10/11/1995 | EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
10/11/1995 | EP0629129A4 Method for kidney tubulogenesis. |
10/11/1995 | CN1109884A Methods of inhibiting myeloperoxidase activity |
10/11/1995 | CN1109752A Methods of inhibiting dysfunctional uterine bleeding |
10/11/1995 | CN1109749A Methods for inhibiting uterine fibrosis |
10/10/1995 | US5457212 Resolution of a thienopyran derivative using methylbenzyl isocyanate; nitration |
10/10/1995 | US5457116 Methods of inhibiting uterine fibrosis |
10/10/1995 | US5457109 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
10/10/1995 | CA1337279C Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
10/05/1995 | WO1995026360A1 Antagonists of endothelin receptors |
10/05/1995 | WO1995026197A1 Adhesion inhibiting composition |
10/05/1995 | WO1995026134A1 Composition for inactivating irritants in fluids |
10/05/1995 | DE4411585A1 Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption A pharmaceutical combination hormonal contraception |
10/05/1995 | DE4411225A1 Verwendung von Carbonsäurederivaten als Arzneimittel The use of carboxylic acid derivatives as medicaments |
10/05/1995 | CA2186377A1 Adhesion inhibiting composition |
10/05/1995 | CA2183767A1 Antagonists of endothelin receptors |
10/04/1995 | EP0675103A2 Derivatives of essential fatty acids and nonsteroidal antiinflammatory drugs |
10/04/1995 | EP0674633A1 Benzopyran derivatives |
10/04/1995 | EP0674521A1 METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17$g(b)-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5$g(a)-ANDROST-1-EN-3-ONES |
10/04/1995 | EP0674509A1 Methods for treatment with dimercaptosuccinic acid (dmsa) |
10/04/1995 | EP0674508A1 4-guanidinobutyramide for improving blood circulation |
10/04/1995 | CN1109330A Methods of inhibiting imperfect tissue repair |
10/03/1995 | US5455275 Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives |
09/28/1995 | WO1995025795A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
09/28/1995 | WO1995025741A1 Gnrh antagonists |
09/28/1995 | WO1995025726A1 QUINAZOLINYL-AMINO DERIVATIVES HAVING α-ANTAGONIST ACTIVITY |
09/28/1995 | WO1995025718A1 Vitamin-d amide derivatives |
09/28/1995 | WO1995025537A1 Drug for relieving side effects caused by immunosuppressants |
09/28/1995 | CA2185813A1 Vitamin-d amide derivatives |
09/28/1995 | CA2185710A1 Gnrh antagonists |
09/27/1995 | EP0673913A1 Calcium-alkali-citrate compounds and their use as medicaments |
09/27/1995 | EP0673650A1 Pharmaceutical sustained-release dosage forms containing alfusozine hydrochloride |
09/27/1995 | EP0673426A1 Platelet-activating factor acetylhydrolase |
09/27/1995 | EP0673371A1 Benzazepinone derivatives |
09/27/1995 | EP0673367A1 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperidines as tachykinin receptor antagonists |
09/27/1995 | EP0510003B1 Piperidine and pyrrolidine derivatives |
09/27/1995 | EP0462189B1 Combination therapy for treatment of estrogen sensitive diseases |
09/27/1995 | CN1109055A 4-aminopyrimidine derivatives |
09/26/1995 | US5453518 Flavone derivatives |